Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
0.5925
+0.0176 (3.06%)
Apr 1, 2025, 9:45 AM EDT - Market open

Unicycive Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Market Capitalization
618230831-
Upgrade
Market Cap Growth
173.36%173.36%270.11%-73.58%--
Upgrade
Enterprise Value
345117113-
Upgrade
Last Close Price
0.570.790.870.542.06-
Upgrade
PS Ratio
-44.688.57--
Upgrade
PB Ratio
8.8111.09-7.92-17.481.87-
Upgrade
P/TBV Ratio
11.0911.09--1.87-
Upgrade
EV/Sales Ratio
-24.771.40--
Upgrade
Debt / Equity Ratio
0.090.09-0.21-0.330.02-0.94
Upgrade
Asset Turnover
--0.080.09--
Upgrade
Quick Ratio
1.081.080.550.147.88-
Upgrade
Current Ratio
1.281.280.760.818.750.07
Upgrade
Return on Equity (ROE)
-2028.11%-2028.11%--225.47%-145.04%-
Upgrade
Return on Assets (ROA)
-87.54%-87.54%-152.67%-104.65%-59.22%-1132.29%
Upgrade
Return on Capital (ROIC)
-787.80%-787.80%--136.93%-67.46%-
Upgrade
Earnings Yield
-61.55%-44.55%-101.28%-221.63%-32.48%-
Upgrade
FCF Yield
-48.01%-34.75%-60.67%-192.11%-18.79%-
Upgrade
Buyback Yield / Dilution
-172.97%-172.97%-62.98%-28.96%-37.37%-4.68%
Upgrade
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q